We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Not Likely to Allow Half-Doses of Moderna’s Vaccine for Younger Patients
U.S. Not Likely to Allow Half-Doses of Moderna’s Vaccine for Younger Patients
Late Monday, the FDA’s two top officials hinted that the agency is unlikely to adopt the Trump administration’s idea of giving two half doses of Moderna’s COVID-19 vaccine to patients aged 18 to 55 in order to double the number of vaccinations being administered, as suggested by Operation Warp Speed’s chief adviser Moncef Slaoui.